Search for Clinical Trial Results

Sponsored By

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - 103 Studies Found

Status Study
Terminated Study Name: Abatacept in ANCA Associated Vasculitis
Condition: ANCA-associated Vasculitis
Date: 2007-06-01
Interventions: Drug: Abatacept (Orencia) 500mg for patients under 60kg 75
Recruiting Study Name: A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
Condition: ANCA-Associated Vasculitis
Date: 2016-12-11
Interventions:
  • Drug: CCX168 Orally administer
Terminated Study Name: Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
Condition: ANCA-Associated Vasculitis
Date: 2013-08-29
Interventions: Procedure: Venipuncture for blood sample collection Analysis samples from the blood sample collection at
Withdrawn Study Name: Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Date: 2010-12-13
Interventions:
  • Drug: Standard of care treatment

Terminated Study Name: The Clinical Efficacy of DFPP in Patients With AAGN
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Date: 2014-06-03
Interventions:
  • Other: DFPP&CTX

Withdrawn Study Name: Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Date: 2011-01-10
Interventions:
  • Drug: Retinoic acid Patients w
Completed Study Name: Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis
Condition: ANCA-associated Vasculitis
Date: 2014-08-19
Interventions:
  • Drug: CCX168 low dose plus standard of care
Active, not recruiting Study Name: CMV Modulation of the Immune System in ANCA-associated Vasculitis
Condition:
  • ANCA Associated Vasculitis
  • CMV Infection

Date: 2012-06-29
Interventions: Drug: Valaciclovir 2g q.d.s. orally for 6 months (dose adjusted according to renal function)
Completed Study Name: Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis
Condition:
  • Pneumococcal Infection
  • ANCA-associated Vasculitis

Date: 2015-05-12
Recruiting Study Name: Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis
Condition:
  • Pneumococcal Infection
  • ANCA-associated Vasculitis

Date: 2015-05-12
Next >>>